Dashboard
Manage Tickers

ATAI ATAI Life Sciences N.V.

Nasdaq atai.life


$ 5.65 $ -0.48 (-8.05 %)    

Thursday, 16-Oct-2025 19:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 5.48
$ 6.00
$ 5.58 x 24
$ 5.65 x 96
$ 5.48 - $ 6.09
$ 1.04 - $ 6.30
6,642,338
na
1.17B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-24-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

atai-life-sciences-announces-proposed-public-offering-terms-not-disclosed
atai Life Sciences Announces Proposed Publ...
10/16/2025 20:13:52

atai-life-sciences-and-beckley-psytech-announces-that-fda-has-granted-breakthrough-therapy-designation-to-their-bpl-003-nasal-spray-for-adults-with-treatment-resistant-depression
atai Life Sciences And Beckley Psytech Ann...
10/16/2025 20:13:51

Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies...

atai-life-sciences-remains-undervalued-analyst-initiates-with-around-125-stock-upside
Atai Life Sciences Remains Undervalued, An...
10/13/2025 18:21:17

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion s...

Core News & Articles
'Psychedelics Show Promise As An 'Entirely...
10/13/2025 17:28:47

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

needham-initiates-coverage-on-atai-life-sciences-with-buy-rating-announces-price-target-of-12
Needham Initiates Coverage On ATAI Life Sc...
10/13/2025 10:08:07

Needham analyst Ami Fadia initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Targe...

Core News & Articles
'New York Lawmakers Hold Hearing Psilocybi...
10/02/2025 15:03:14

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

atai-life-sciences-nv-says-certain-selling-securityholders-may-offer-and-sell-common-shares-including-up-to-453m-shares-by-selling-securityholders
ATAI Life Sciences N.V. Says Certain Selli...
09/29/2025 21:40:45

-SEC Filing

atai-life-sciences-nv-files-for-potential-mixed-shelf-size-not-disclosed
Atai Life Sciences N.V. Files For Potentia...
09/29/2025 21:33:12

-SEC Filing

alibaba-lithium-americas-and-other-big-stocks-moving-higher-in-wednesdays-pre-market-session
Alibaba, Lithium Americas And Other Big St...
09/24/2025 10:34:48

demystifying-atai-life-sciences-insights-from-5-analyst-reviews
Demystifying ATAI Life Sciences: Insights ...
09/23/2025 22:00:37

atai-life-sciences-experimental-depression-drug-shows-sustained-benefit-in-treatment-resistant-patients
Atai Life Sciences Experimental Depression...
09/23/2025 18:50:10

Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 tria...

hc-wainwright--co-reiterates-buy-on-atai-life-sciences-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on ATAI...
09/23/2025 14:56:00

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Buy and maintains $15...

atai-life-sciences-and-beckley-psytech-announce-clinical-evidence-supporting-two-dose-induction-of-bpl-003-with-sustained-antidepressant-benefits
Atai Life Sciences And Beckley Psytech Ann...
09/23/2025 11:05:34

 Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with t...

cathie-woods-ark-bets-big-on-solana-treasury-play-makes-162m-investment-in-brera-holdings-as-stock-explodes-225
Cathie Wood's Ark Bets Big On Solana Treas...
09/19/2025 01:42:06

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and b...

atai-life-sciences-awarded-multi-year-milestone-driven-grant-worth-up-to-114m-by-national-institute-on-drug-abuse-part-of-national-institutes-of-health
atai Life Sciences Awarded Multi-Year, Mil...
09/18/2025 12:11:11

atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company"), a clinical-stage biopharmaceutical company on a mission...

Core News & Articles
'Massachusetts Lawmakers Approve Bill To C...
09/12/2025 16:30:15

https://www.marijuanamoment.net/massachusetts-lawmakers-approve-bill-to-create-psychedelic-therapy-pilot-program/

Core News & Articles
'Military To Start Testing Service Members...
08/28/2025 18:16:26

https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

Core News & Articles
'GOP Senator Is 'Confident' Psychedelics A...
08/22/2025 19:53:09

https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak...

Core News & Articles
'U.S. Senate Committee To Hold Hearing On ...
08/21/2025 18:35:07

https://www.marijuanamoment.net/u-s-senate-committee-to-hold-hearing-on-benefits-of-psychedelics-for-military-veterans/

atai-life-sciences-q2-eps-014-misses-012-estimate-sales-719000k-up-from-273000k-yoy
ATAI Life Sciences Q2 EPS $(0.14) Misses $...
08/14/2025 11:17:02

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION